HER2 + GASTRIC CANCER
Clinical trials for HER2 + GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + GASTRIC CANCER trials appear
Sign up with your email to follow new studies for HER2 + GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on hard-to-treat HER2 cancers, including brain tumors
Disease control Recruiting nowThis early-phase trial tests an experimental drug called IAM1363 in people with advanced cancers that have HER2 alterations. The study aims to find a safe dose and see if the drug can shrink tumors, including those that have spread to the brain. About 383 adults whose cancer has …
Matched conditions: HER2 + GASTRIC CANCER
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New triple-drug attack targets hard-to-treat stomach cancer
Disease control Recruiting nowThis study tests a new three-drug combination for people with advanced stomach or esophageal cancer that has spread and has specific markers (HER2 and PD-L1). About 80 participants will receive zanidatamab, pembrolizumab, and chemotherapy. The goal is to see if this combination c…
Matched conditions: HER2 + GASTRIC CANCER
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 07, 2026 18:42 UTC